Hjem › Akut lymfoblastisk leukemi › Maryland › Baltimore
Kliniske studier for Akut lymfoblastisk leukemi i Baltimore, MD
9 studier for Akut lymfoblastisk leukemi søker deltakere på steder i og rundt Baltimore (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 2 flere
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RekruttererFrivillige helsepersonell ønskes velkommen
- Johns Hopkins University School of Medicine, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Johns Hopkins, Baltimore
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservasjonsstudie
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Sibley Memorial Hospital, Baltimore
- University of Maryland, Baltimore
- Johns Hopkins Main Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekruttererFase 1
- University of Maryland, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Johns Hopkins University, Baltimore
Akut lymfoblastisk leukemi-studier i andre byer
- Houston, TX28 studier
- New York City, NY24 studier
- Baldwin Park, CA21 studier
- Seattle, WA21 studier
- Chicago, IL19 studier
- Atlanta, GA19 studier
- Philadelphia, PA16 studier
- Memphis, TN16 studier
- Washington, DC16 studier
- Boston, MA15 studier
- Los Angeles, CA14 studier
- Durham, NC13 studier
Andre studier i Baltimore
- Ikke-småcellet lungekreft60 studier
- Brystkreft47 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Kreft (alle typer)37 studier
- Kolorektal kreft31 studier
- Pankreaskreft31 studier
- Metastatisk kreft28 studier
- Fedme25 studier
- Hjertesvikt24 studier
- Blærekreft24 studier
- Slag22 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.